WuXi生物logics揭幕了WuXihihihighTM2.0, 增加药物浓度和减轻病人注射。 WuXi Biologics unveils WuXiHigh™2.0, boosting drug concentration and easing patient injections.

WuXi生物logics已经启动了WuXihihihighTM2.0,这是一个新的高浓度生物实验平台,其蛋白浓度达到230毫克/毫升/升,粘度减少90%。 WuXi Biologics has launched WuXiHigh™2.0, a new platform for high-concentration biologics, achieving protein concentrations of up to 230 mg/mL and reducing viscosity by up to 90%. 这项技术旨在通过减少注射量和提高剂量效率,同时保持药效,改善病人的经验。 This technology aims to improve patient experience by reducing injection volume and enhancing dosing efficiency, while maintaining drug efficacy. 该平台支持从临床到商业阶段的无缝开发。 The platform supports seamless development from clinical to commercial stages.